Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy in CNS Disorder Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy in CNS Disorder Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Alzheimer's Disease
1.3.3 Huntington's Disease
1.3.4 Parkinson's Disease
1.3.5 Batten Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy in CNS Disorder Market Perspective (2018-2029)
2.2 Gene Therapy in CNS Disorder Growth Trends by Region
2.2.1 Global Gene Therapy in CNS Disorder Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy in CNS Disorder Historic Market Size by Region (2018-2024)
2.2.3 Gene Therapy in CNS Disorder Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy in CNS Disorder Market Dynamics
2.3.1 Gene Therapy in CNS Disorder Industry Trends
2.3.2 Gene Therapy in CNS Disorder Market Drivers
2.3.3 Gene Therapy in CNS Disorder Market Challenges
2.3.4 Gene Therapy in CNS Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy in CNS Disorder Players by Revenue
3.1.1 Global Top Gene Therapy in CNS Disorder Players by Revenue (2018-2024)
3.1.2 Global Gene Therapy in CNS Disorder Revenue Market Share by Players (2018-2024)
3.2 Global Gene Therapy in CNS Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy in CNS Disorder Revenue
3.4 Global Gene Therapy in CNS Disorder Market Concentration Ratio
3.4.1 Global Gene Therapy in CNS Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy in CNS Disorder Revenue in 2022
3.5 Gene Therapy in CNS Disorder Key Players Head office and Area Served
3.6 Key Players Gene Therapy in CNS Disorder Product Solution and Service
3.7 Date of Enter into Gene Therapy in CNS Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy in CNS Disorder Breakdown Data by Type
4.1 Global Gene Therapy in CNS Disorder Historic Market Size by Type (2018-2024)
4.2 Global Gene Therapy in CNS Disorder Forecasted Market Size by Type (2024-2029)
5 Gene Therapy in CNS Disorder Breakdown Data by Application
5.1 Global Gene Therapy in CNS Disorder Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapy in CNS Disorder Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy in CNS Disorder Market Size (2018-2029)
6.2 North America Gene Therapy in CNS Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapy in CNS Disorder Market Size by Country (2018-2024)
6.4 North America Gene Therapy in CNS Disorder Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy in CNS Disorder Market Size (2018-2029)
7.2 Europe Gene Therapy in CNS Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapy in CNS Disorder Market Size by Country (2018-2024)
7.4 Europe Gene Therapy in CNS Disorder Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy in CNS Disorder Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapy in CNS Disorder Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapy in CNS Disorder Market Size by Region (2018-2024)
8.4 Asia-Pacific Gene Therapy in CNS Disorder Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy in CNS Disorder Market Size (2018-2029)
9.2 Latin America Gene Therapy in CNS Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapy in CNS Disorder Market Size by Country (2018-2024)
9.4 Latin America Gene Therapy in CNS Disorder Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy in CNS Disorder Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapy in CNS Disorder Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2018-2024)
10.4 Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Voyager Therapeutics
11.1.1 Voyager Therapeutics Company Detail
11.1.2 Voyager Therapeutics Business Overview
11.1.3 Voyager Therapeutics Gene Therapy in CNS Disorder Introduction
11.1.4 Voyager Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2024)
11.1.5 Voyager Therapeutics Recent Development
11.2 Spark Therapeutics
11.2.1 Spark Therapeutics Company Detail
11.2.2 Spark Therapeutics Business Overview
11.2.3 Spark Therapeutics Gene Therapy in CNS Disorder Introduction
11.2.4 Spark Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2024)
11.2.5 Spark Therapeutics Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Gene Therapy in CNS Disorder Introduction
11.3.4 Novartis AG Revenue in Gene Therapy in CNS Disorder Business (2018-2024)
11.3.5 Novartis AG Recent Development
11.4 Bluebird Bio Inc.
11.4.1 Bluebird Bio Inc. Company Detail
11.4.2 Bluebird Bio Inc. Business Overview
11.4.3 Bluebird Bio Inc. Gene Therapy in CNS Disorder Introduction
11.4.4 Bluebird Bio Inc. Revenue in Gene Therapy in CNS Disorder Business (2018-2024)
11.4.5 Bluebird Bio Inc. Recent Development
11.5 Biogen
11.5.1 Biogen Company Detail
11.5.2 Biogen Business Overview
11.5.3 Biogen Gene Therapy in CNS Disorder Introduction
11.5.4 Biogen Revenue in Gene Therapy in CNS Disorder Business (2018-2024)
11.5.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy in CNS Disorder Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Gene Therapy in CNS Disorder Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy in CNS Disorder Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy in CNS Disorder Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene Therapy in CNS Disorder Market Share by Region (2018-2024)
Table 8. Global Gene Therapy in CNS Disorder Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy in CNS Disorder Market Share by Region (2024-2029)
Table 10. Gene Therapy in CNS Disorder Market Trends
Table 11. Gene Therapy in CNS Disorder Market Drivers
Table 12. Gene Therapy in CNS Disorder Market Challenges
Table 13. Gene Therapy in CNS Disorder Market Restraints
Table 14. Global Gene Therapy in CNS Disorder Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene Therapy in CNS Disorder Market Share by Players (2018-2024)
Table 16. Global Top Gene Therapy in CNS Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in CNS Disorder as of 2022)
Table 17. Ranking of Global Top Gene Therapy in CNS Disorder Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gene Therapy in CNS Disorder Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy in CNS Disorder Product Solution and Service
Table 21. Date of Enter into Gene Therapy in CNS Disorder Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy in CNS Disorder Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene Therapy in CNS Disorder Revenue Market Share by Type (2018-2024)
Table 25. Global Gene Therapy in CNS Disorder Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy in CNS Disorder Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy in CNS Disorder Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene Therapy in CNS Disorder Revenue Market Share by Application (2018-2024)
Table 29. Global Gene Therapy in CNS Disorder Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy in CNS Disorder Revenue Market Share by Application (2024-2029)
Table 31. North America Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy in CNS Disorder Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Gene Therapy in CNS Disorder Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gene Therapy in CNS Disorder Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Gene Therapy in CNS Disorder Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy in CNS Disorder Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gene Therapy in CNS Disorder Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy in CNS Disorder Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gene Therapy in CNS Disorder Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Gene Therapy in CNS Disorder Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy in CNS Disorder Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy in CNS Disorder Market Size by Country (2024-2029) & (US$ Million)
Table 46. Voyager Therapeutics Company Detail
Table 47. Voyager Therapeutics Business Overview
Table 48. Voyager Therapeutics Gene Therapy in CNS Disorder Product
Table 49. Voyager Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2024) & (US$ Million)
Table 50. Voyager Therapeutics Recent Development
Table 51. Spark Therapeutics Company Detail
Table 52. Spark Therapeutics Business Overview
Table 53. Spark Therapeutics Gene Therapy in CNS Disorder Product
Table 54. Spark Therapeutics Revenue in Gene Therapy in CNS Disorder Business (2018-2024) & (US$ Million)
Table 55. Spark Therapeutics Recent Development
Table 56. Novartis AG Company Detail
Table 57. Novartis AG Business Overview
Table 58. Novartis AG Gene Therapy in CNS Disorder Product
Table 59. Novartis AG Revenue in Gene Therapy in CNS Disorder Business (2018-2024) & (US$ Million)
Table 60. Novartis AG Recent Development
Table 61. Bluebird Bio Inc. Company Detail
Table 62. Bluebird Bio Inc. Business Overview
Table 63. Bluebird Bio Inc. Gene Therapy in CNS Disorder Product
Table 64. Bluebird Bio Inc. Revenue in Gene Therapy in CNS Disorder Business (2018-2024) & (US$ Million)
Table 65. Bluebird Bio Inc. Recent Development
Table 66. Biogen Company Detail
Table 67. Biogen Business Overview
Table 68. Biogen Gene Therapy in CNS Disorder Product
Table 69. Biogen Revenue in Gene Therapy in CNS Disorder Business (2018-2024) & (US$ Million)
Table 70. Biogen Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy in CNS Disorder Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Gene Therapy in CNS Disorder Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Therapy Features
Figure 4. Non-viral Gene Therapy Features
Figure 5. Global Gene Therapy in CNS Disorder Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Gene Therapy in CNS Disorder Market Share by Application: 2022 VS 2029
Figure 7. Alzheimer's Disease Case Studies
Figure 8. Huntington's Disease Case Studies
Figure 9. Parkinson's Disease Case Studies
Figure 10. Batten Disease Case Studies
Figure 11. Gene Therapy in CNS Disorder Report Years Considered
Figure 12. Global Gene Therapy in CNS Disorder Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Gene Therapy in CNS Disorder Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gene Therapy in CNS Disorder Market Share by Region: 2022 VS 2029
Figure 15. Global Gene Therapy in CNS Disorder Market Share by Players in 2022
Figure 16. Global Top Gene Therapy in CNS Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in CNS Disorder as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy in CNS Disorder Revenue in 2022
Figure 18. North America Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Gene Therapy in CNS Disorder Market Share by Country (2018-2029)
Figure 20. United States Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gene Therapy in CNS Disorder Market Share by Country (2018-2029)
Figure 24. Germany Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy in CNS Disorder Market Share by Region (2018-2029)
Figure 32. China Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Gene Therapy in CNS Disorder Market Share by Country (2018-2029)
Figure 40. Mexico Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy in CNS Disorder Market Share by Country (2018-2029)
Figure 44. Turkey Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Gene Therapy in CNS Disorder Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Voyager Therapeutics Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2024)
Figure 47. Spark Therapeutics Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2024)
Figure 48. Novartis AG Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2024)
Figure 49. Bluebird Bio Inc. Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2024)
Figure 50. Biogen Revenue Growth Rate in Gene Therapy in CNS Disorder Business (2018-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed